C. Kakinuma et al., TROPHOBLASTIC APOPTOSIS IN MICE WITH PRETERM DELIVERY AND ITS SUPPRESSION BY URINARY TRYPSIN-INHIBITOR, Obstetrics and gynecology, 90(1), 1997, pp. 117-124
Objective: To investigate histopathologic changes of the placenta in m
ice with preterm delivery induced by lipopolysaccharide and the effect
of urinary trypsin inhibitor. Methods: Female C3H/HeN mice impregnate
d by male B6D2F1 mice were treated with lipopolysaccharide (50 mu g/kg
, intraperitoneally) or lipopolysaccharide plus urinary trypsin inhibi
tor (25 x 10(4) U/kg, intraperitoneally). At 3, 6, 9, and 18 hours aft
er the second dose of lipopolysaccharide, and at delivery in the contr
ol and urinary trypsin inhibitor-treated groups, the concentrations of
interleukin-1 alpha and tumor necrosis factor-alpha were determined i
n serum and amniotic fluid. Subsequently, the placentas were examined.
In the same manner, we examined mice treated with interleukin-1 alpha
(250 mu g/kg, subcutaneously) on day 15 of pregnancy and intact mice
on days 15 and 18 of pregnancy as well as at delivery. To assess the d
irect action of cytokines, we cultured placental slices with tumor nec
rosis factor-alpha, interleukin-1 alpha, or tumor necrosis factor-alph
a plus urinary trypsin inhibitor and examined them morphologically. Re
sults: Control mice were characterized by trophoblastic apoptosis and
increased serum levels of tumor necrosis factor-alpha and interleukin-
1 alpha. In contrast, urinary trypsin inhibitor-treated mice showed su
ppression of apoptosis and lower cytokine levels. Interleukin-1 alpha
induced trophoblastic apoptosis and increased the serum level of tumor
necrosis factor-alpha. The in vitro study showed that tumor necrosis
factor-alpha directly induced trophoblastic apoptosis in placental sli
ces. Conclusion: We demonstrated that trophoblastic apoptosis occurs i
n the placentas of a mouse model with preterm delivery induced by lipo
polysaccharide. We postulated that apoptosis may lead to placental abr
uption, and its development may be prevented by treatment with urinary
trypsin inhibitor. (C) 1997 by The American College of Obstetricians
and Gynecologists.